TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34184784

Group type: EXPERIMENTAL
Intervention: Short sleep
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Long sleep
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Sometimes insomnia
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Usually insomnia
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Definite eveningness
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Definite morningness
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Short sleep (men)
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Short sleep (premenopausal women)
Number of subjects: 398137

Group type: EXPERIMENTAL
Intervention: Short sleep, eveningness, and daytime sleepiness (postmenopausal women)
Number of subjects: 398137

Group type: COMPARATOR
Intervention: Mendelian randomization analyses
Number of subjects: 398137
Study: 34058910

Group type: EXPERIMENTAL
Intervention: Laryngoplasty or voice therapy
Number of subjects: 439

Group type: COMPARATOR
Intervention: Voice therapy alone
Number of subjects: 439

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 439
Study: 34639285

Group type: EXPERIMENTAL
Intervention: In-service training program
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study: 34010180

Group type: EXPERIMENTAL
Intervention: PCI with everolimus‐eluting stents
Number of subjects: 1895

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Increasing WBCc tertiles (mean 5.6, 7.5, and 10.1 × 10^9/L)
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: WBCc as a continuous variable
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: WBCc tertiles
Number of subjects: 1895
Study: 32526017

Group type: EXPERIMENTAL
Intervention: tDCS + exercise therapies
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham tDCS + exercise therapies
Number of subjects: 60
Study: 36457045

Group type: EXPERIMENTAL
Intervention: digital cognitive-behavioral therapy for insomnia (dCBT-I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: clinician-led cognitive-behavioral therapy for insomnia (CBT-I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: sleep education control
Number of subjects: 0
Study: 33259846

Group type: EXPERIMENTAL
Intervention: ILMN_1765146 tagging IFNAR2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ILMN_1791057 tagging IFNAR2
Number of subjects: 0
Study: 36261277

Group type: EXPERIMENTAL
Intervention: 2-week interruption in methotrexate treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continued methotrexate treatment
Number of subjects: 0
Study: 34554692

Group type: EXPERIMENTAL
Intervention: Selenium 200 µg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35452086

Group type: EXPERIMENTAL
Intervention: Capecitabine maintenance therapy using lower dosage and higher frequency
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study: 33303575

Group type: EXPERIMENTAL
Intervention: Anti-PD1 immunotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small-molecule inhibitor targeting HO-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum ox-LDL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher HMOX1 (HO-1) expression
Number of subjects: 0
Study: 34877769

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Buprenorphine-naloxone (BUP-NX)
Number of subjects: 474
Study: 33009852

Group type: EXPERIMENTAL
Intervention: Take 5 Minutes treatment (5 to 10 minutes of dedicated communication with parents)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Take 5 Minutes treatment
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 191
Study: 34719633

Group type: EXPERIMENTAL
Intervention: Complete denture relined with silicone-based resilient denture liner (RD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional complete denture (CD)
Number of subjects: 0
Study: 34246226

Group type: EXPERIMENTAL
Intervention: Monthly fremanezumab (225 mg)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Quarterly fremanezumab (225 mg)
Number of subjects: 807

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 807
Study: 33303576

Group type: EXPERIMENTAL
Intervention: EPHA mutation (EPHAmut)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: EPHA mutation (EPHAmut) in cohort 1
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: EPHA mutation (EPHAmut) in cohort 2
Number of subjects: 79
Study: 36168844

Group type: EXPERIMENTAL
Intervention: Abemaciclib + fulvestrant
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo + fulvestrant
Number of subjects: 212
Study: 34000886

Group type: EXPERIMENTAL
Intervention: Standard care plus intervention (palliative rehabilitation) - 12-week intervention with two mandatory consultations and interdisciplinary group program
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard oncology care (control group)
Number of subjects: 288
Study: 32880602

Group type: EXPERIMENTAL
Intervention: Eribulin plus Pembrolizumab (Eribulin 1.4 mg/m2 IV on days 1 and 8 plus Pembrolizumab 200 mg/m2 IV on day 1 of a 21-day cycle)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Eribulin alone
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Crossover treatment with Pembrolizumab after progression on Eribulin monotherapy
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups (Eribulin with Pembrolizumab and Eribulin alone)
Number of subjects: 88
Study: 33510373

Group type: EXPERIMENTAL
Intervention: Lower-body dynamic exercise (walking at 65-70% of HRmax)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dynamic upper-body exercise (three 5 min workloads, 56-80% of HRmax)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Static upper-body exercise (five 1.5 min work cycles, 10-30% of maximal voluntary contraction)
Number of subjects: 26
Study: 32783267

Group type: EXPERIMENTAL
Intervention: 0.7% fumaric acid treatment on fiber post surface and 0.7% fumaric acid treatment on dentin surface
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 9% hydrofluoric acid treatment on fiber post surface and 0.7% fumaric acid treatment on dentin surface
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no conditioning) on dentin surface and 9% hydrofluoric acid treatment on fiber post surface
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 17% EDTA treatment on dentin surface and 9% hydrofluoric acid treatment on fiber post surface
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.7% fumaric acid treatment on dentin surface and 9% hydrofluoric acid treatment on fiber post surface
Number of subjects: 60
Study: 33610736

Group type: EXPERIMENTAL
Intervention: SRP + PDT
Number of subjects: 84

Group type: COMPARATOR
Intervention: SRP only
Number of subjects: 84
Study: 34182194

Group type: EXPERIMENTAL
Intervention: OT+XNJ (i.v. 20 ml/daily)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: OT+low dose-YB (oral, 1,000 mg/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: OT+high dose-YB (oral, 2,000 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: OT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: XNJ, l-YB, h-YB
Number of subjects: 80
Study: 35380346

Group type: EXPERIMENTAL
Intervention: Specialized medical home intervention
Number of subjects: 331

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 331
Study: 33972573

Group type: EXPERIMENTAL
Intervention: PT150 (900 mg/day) administered orally for five days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (1% ethanol) beverage
Number of subjects: 11
Study: 35220954

Group type: EXPERIMENTAL
Intervention: High flow oxygen supply
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard oxygen
Number of subjects: 0
Study: 33657674

Group type: EXPERIMENTAL
Intervention: Group-based rehabilitation (GBR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Individual-based rehabilitation (IBR)
Number of subjects: 80
Study: 32776907

Group type: EXPERIMENTAL
Intervention: supplemented Er‐xian decoction combined with acupoint application
Number of subjects: 80

Group type: COMPARATOR
Intervention: Kuntai capsule
Number of subjects: 80
Study: 34664772

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/Standard of Care
Number of subjects: 0
Study: 34915594

Group type: EXPERIMENTAL
Intervention: Face-to-face delivery/conventional reduced energy diet (n = 36)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Remote delivery (RD)/conventional reduced energy diet (n = 39)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: RD/reduced energy enhanced stop light diet (eSLD) (n = 35)
Number of subjects: 110

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 110
Study: 32187070

Group type: EXPERIMENTAL
Intervention: Millard repair
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Onizuka repair
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fisher repair
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Millard repair (cut-as-you-go policy)
Number of subjects: 50
Study: 32156255

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Personalized dosage of MPH
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: MPH over treatment period
Number of subjects: 221
Study: 35747337

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Supportive counselling (SC)
Number of subjects: 45
Study: 33305631

Group type: EXPERIMENTAL
Intervention: OLNP-06, 200 mg twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo, 200 mg twice daily
Number of subjects: 50
Study: 33210806

Group type: EXPERIMENTAL
Intervention: Massage (15-minute massage on calf muscles)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) (15 ± 1°C for 15 minutes)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Passive Rest
Number of subjects: 78
Study: 35410182

Group type: EXPERIMENTAL
Intervention: Behaviour change communication intervention on hypertension and diabetes
Number of subjects: 0
Study: 32701529

Group type: EXPERIMENTAL
Intervention: TXA with microneedling
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intraderma injection of TXA
Number of subjects: 56
Study: 34271197

Group type: EXPERIMENTAL
Intervention: Psychosexual education through e-learning for 8 weeks
Number of subjects: 38
Study: 33260939

Group type: EXPERIMENTAL
Intervention: Recommended behavior group (RB group) - drank 200 mL of water every 2 h
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Half amount group (HA group) - drank 100 mL of water every 2 h
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: High frequency group (HF group) - drank 110 mL of water every 1 h
Number of subjects: 92
Study: 36268614

Group type: EXPERIMENTAL
Intervention: Home-based Intensive Nutrition Therapy (HINT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard Medical Therapy (SMT)
Number of subjects: 100
Study: 32856209

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 16 mg twice daily for 7 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32534981

Group type: EXPERIMENTAL
Intervention: Advance care directive present
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Resuscitation plan/order present
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Acknowledgment of advance care directive or resuscitation plans/orders in clinical notes
Number of subjects: 300
Study: 36303651

Group type: EXPERIMENTAL
Intervention: Emergency contraceptive use during the pandemic (March 2020)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergency contraceptive use post-March 2020
Number of subjects: 0

Group type: COMPARATOR
Intervention: Emergency contraceptive use pre-pandemic
Number of subjects: 0
Study: 34273413

Group type: EXPERIMENTAL
Intervention: Odors of different valences (four odors plus odorless air) presented in randomized order
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Odors of different valences
Number of subjects: 62
Study: 33980184

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 0.08 mg/kg oxycodone immediately after completion of the surgical procedure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline injection (Control group)
Number of subjects: 100
Study: 35184297

Group type: EXPERIMENTAL
Intervention: CDX-0159 (0.3, 1, 3, and 9 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 34318560

Group type: EXPERIMENTAL
Intervention: Hypoxia (12% O2)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normoxia (21% O2)
Number of subjects: 8
Study: 34649747

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite and titanium-coated monoblock shell with an integrated ceramic-on-ceramic bearing (n = 40)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Porous-coated modular metal-on-polyethylene acetabular component (n = 46)
Number of subjects: 86
Study: 33839885

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 802
Study: 33239632

Group type: EXPERIMENTAL
Intervention: Maternal 'Health-conscious' dietary pattern
Number of subjects: 325
Study: 36302893

Group type: EXPERIMENTAL
Intervention: HTI vaccines (DNA.HTI, MVA.HTI, ChAdOx1.HTI)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: HTI vaccines
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 34336620

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ECSWT) - three sessions, once a week for three weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phonophoresis therapy - ultrasound using hydrocortisone gel 1% over the trigger point, three times a week for three weeks
Number of subjects: 40
Study: 35879422

Group type: EXPERIMENTAL
Intervention: Smart model education set and theoretical expression (Group 2)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Smart model education set (Group 3)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Classical education (Group 1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Smart model education set (Group 2)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups (Group 1, 2, 3)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Trait anxiety scale (all groups)
Number of subjects: 3
Study: 35133995

Group type: EXPERIMENTAL
Intervention: Self-massage and stretching only
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Self-massage and stretching plus gastrocnemius exercise
Number of subjects: 28
Study: 36099260

Group type: EXPERIMENTAL
Intervention: tDCS with the anode on primary motor cortex and cathode on the contralateral forehead
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 52
Study: 33909860

Group type: EXPERIMENTAL
Intervention: 1.23% acidulated phosphate fluoride (APF) gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-fluoridated gel (control)
Number of subjects: 80
Study: 34044625

Group type: EXPERIMENTAL
Intervention: Web-based communication between a nurse and a family member for four consecutive days for 10 to 15 minutes
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no web-based communication)
Number of subjects: 67
Study: 33955714

Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 0
Study: 32483058

Group type: EXPERIMENTAL
Intervention: Hypnotic cognitive therapy
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Standard cognitive therapy
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Hypnosis focused on pain reduction
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Pain education
Number of subjects: 173

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 173
Study: 35411880

Group type: EXPERIMENTAL
Intervention: Individualized Assisted Walking Program (IAWP)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 307
Study: 33506388

Group type: EXPERIMENTAL
Intervention: Home telemonitoring group
Number of subjects: 1380

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1380
Study: 32248825

Group type: EXPERIMENTAL
Intervention: EMPOWER‐SUSTAIN intervention for 6 months
Number of subjects: 232

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: EMPOWER‐SUSTAIN intervention
Number of subjects: 232
Study: 34529329

Group type: EXPERIMENTAL
Intervention: aPDT + Curcumin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: aPDT + Riboflavin
Number of subjects: 63

Group type: COMPARATOR
Intervention: 5.25% NaOCl (positive control)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No intervention (negative control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Riboflavin + LED
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Curcumin + LED
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: LED
Number of subjects: 63
Study: 33053090

Group type: EXPERIMENTAL
Intervention: Dysphagia Risk Evaluation Protocol (DREP) - screening version
Number of subjects: 211
Study: 34277384

Group type: EXPERIMENTAL
Intervention: Nasal Saline + Triamcinolone Acetonide
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Nasal Saline
Number of subjects: 150

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 150
Study: 32248771

Group type: EXPERIMENTAL
Intervention: Alteplase at 0.6 mg/kg
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 131
Study: 34969619

Group type: EXPERIMENTAL
Intervention: Music therapy (nonverbal and instrumental music in the forms of taqsim, saz semai, and peshrev at speeds of 60 and 100)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 62
Study: 32316938

Group type: EXPERIMENTAL
Intervention: Magnesium citrate 300 mg
Number of subjects: 829

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 829
Study: 35141971

Group type: EXPERIMENTAL
Intervention: Voice treatment (n = 6)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Articulation treatment (n = 7)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No treatment (n = 6)
Number of subjects: 19
Study: 33197668

Group type: EXPERIMENTAL
Intervention: Six weeks of twice‐weekly Swedish Massage Therapy (SMT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Additional six weeks of twice‐weekly Swedish Massage Therapy (SMT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Active control (not specified)
Number of subjects: 11
Study: 32431023

Group type: EXPERIMENTAL
Intervention: Fatigue Severity Scale (FSS-7) assessment at inclusion, 3 months after stroke, and at follow-up 18 months later
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Time spent walking
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Sedentary behaviour, walking, and sedentary bouts
Number of subjects: 145
Study: 35813441

Group type: EXPERIMENTAL
Intervention: Comprehensive care based on appropriate Chinese medicine techniques
Number of subjects: 148

Group type: COMPARATOR
Intervention: Comprehensive care
Number of subjects: 148
Study: 34077684

Group type: EXPERIMENTAL
Intervention: D‐fortified yogurt drink (DY; 1000 IU vitamin D/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ca‐D‐fortified yogurt drink (CDY; 1000 IU vitamin D plus 500 mg calcium)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Plain yogurt drink (Control)
Number of subjects: 75
Study: 32159395

Group type: EXPERIMENTAL
Intervention: Prediabetics with high plasma ghrelin levels
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Diabetics
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Diabetics, prediabetics (IFG + IGT), NGT
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: IGT and diabetes groups
Number of subjects: 1045
Study: 35255402

Group type: EXPERIMENTAL
Intervention: Intensive physiotherapy group (manual interventions, exercise, insoles)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Home-based exercise group (exercise, insoles)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Insole group (insoles)
Number of subjects: 39
Study: 34389250

Group type: EXPERIMENTAL
Intervention: Lower dose of ethambutol (12.5 mg/kg/d)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Higher dose of ethambutol (15.4 mg/kg/d)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Higher dose of ethambutol
Number of subjects: 76

Group type: COMPARATOR
Intervention: Lower dose of ethambutol
Number of subjects: 76

Group type: COMPARATOR
Intervention: Both doses of ethambutol
Number of subjects: 76
Study: 34423904

Group type: EXPERIMENTAL
Intervention: Rapastinel 900 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Rapastinel 1800 mg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Alprazolam 0.75 mg (positive control)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/kg (clinical comparator)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 33574564

Group type: EXPERIMENTAL
Intervention: Mapuche women
Number of subjects: 200

Group type: COMPARATOR
Intervention: Non-Mapuche women
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Novel inflammatory biomarkers
Number of subjects: 200
Study: 32664290

Group type: EXPERIMENTAL
Intervention: Whey hydrolysate (WH, n = 9)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Whey isolate (WI, n = 6)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Rice and pea combination (RP, n = 6)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (PL, n = 6)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: All groups (WH, WI, RP, PL)
Number of subjects: 27
Study: 36040184

Group type: EXPERIMENTAL
Intervention: Preoperative oral electrolyte-carbohydrate nutrition supplement (OECNS)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (meal nutrition supplements and water)
Number of subjects: 94